Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email

41M+ vax doses delivered

Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email

The Philippines has administered 41,247,552 doses of COVID-19 vaccines nationwide as of Sept. 18, the National Task Force Against Covid-19 reported on Sunday.

Based on the National Covid-19 vaccination dashboard data, there are 22,771,602 Filipinos who have received the first dose while 18,475,950 are now fully protected against the dreaded disease.

The average daily doses administered in the last seven days stood at 374,612 doses.

The Philippines’ jabs stockpile has 59,359,810 doses, with an additional 3 million of Sinovac and 2,020,590 Pfizer vaccines to be delivered on Sunday night.

In an interview over the weekend, vaccine czar and NTF chief Secretary Carlito Galvez Jr. said the government aims to fully vaccinate over 20 million by end of September.

He added the government is expecting a higher turnout from over 2,000 operating vaccination sites nationwide as regions and provinces have expanded their rollouts to essential workers and indigent residents.

“This is a testament that our vaccination program is on track and is continuously scaling up despite the multiple challenges we have faced in the past weeks,” Galvez said earlier.

In the coming weeks, the Philippines will also receive 12 million doses of government-procured Sinovac, 10 million doses of Pfizer-BioNTech through the COVAX Facility, 5 million doses of government-purchased Pfizer, 4 million doses of government and private sector-procured Moderna, 1 million doses of Sputnik Light, 1 million doses of the private sector and LGU-procured AstraZeneca, and 1 million doses donated by a partner country.

The government targets to vaccinate 70 percent or 77,139,058 Filipinos out of its estimated 110,198,654 population.*PNA

ARCHIVES

Read Article by date

April 2024
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
2930 

Get your copy of the Visayan Daily Star everyday!

Avail of the FREE 30-day trial.